Abbott Laboratories vs. BioMarin Pharmaceuticals Inc
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | BMRN | |
|---|---|---|
| Market Cap | $189.30 billion | $11.07 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | BMRN | |
|---|---|---|
| Dividend Yield | 2.18% | — |
ABT and BMRN split the dividend factors evenly.
Risk & Sentiment
| ABT | BMRN | |
|---|---|---|
| Short Interest | 0.57% | 4.98% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, BMRN overview, BMRN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.